HBT
WST icon

Hills Bank & Trust’s West Pharmaceutical WST Stock Holding History

Hills Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-835
Closed -$230K – 369
2025
Q4 		$230K Sell
835
-602
-42% -$165K 0.01% 262
2025
Q3 		$377K Sell
1,437
-9
-0.6% -$2.19K 0.02% 220
2025
Q2 		$316K Sell
1,446
-30
-2% -$6.41K 0.02% 223
2025
Q1 		$330K Hold
1,476
– – 0.02% 214
2024
Q4 		$483K Hold
1,476
– – 0.04% 189
2024
Q3 		$443K Buy
1,476
+290
+24% +$88.8K 0.03% 192
2024
Q2 		$391K Buy
1,186
+362
+44% +$128K 0.03% 193
2024
Q1 		$326K Buy
+824
New +$305K 0.03% 206

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hills Bank & Trust's WST Position: Q1 2026 in Review

Hills Bank & Trust sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 835 shares — an estimated $230K sold.

Hills Bank & Trust first reported a position in WST in Q1 2024 and held it in 8 quarters. The position peaked at $483K in Q4 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Hills Bank & Trust reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Hills Bank & Trust sold 835 West Pharmaceutical shares in Q1 2026, an estimated $230K.
  • Hills Bank & Trust first reported a position in West Pharmaceutical in Q1 2024 and held it in 8 quarters.
  • Hills Bank & Trust's West Pharmaceutical position peaked at $483K in Q4 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.